STK33 and breast carcinoma: Moreover, the results indicated that elevated expression of STK33 and CCAR1 correlated with poor survival in breast cancer, suggesting that the STK33‐CCAR1 axis is likely to be a robust biomarker for predicting the prognosis of TNBC.